Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

1,1-Dioxo-5,6-dihydro-[4,1,2]oxathiazines, a novel class of 11ß-HSD1 inhibitors for the treatment of diabetes.

Böhme T, Engel CK, Farjot G, Güssregen S, Haack T, Tschank G, Ritter K.

Bioorg Med Chem Lett. 2013 Aug 15;23(16):4685-91. doi: 10.1016/j.bmcl.2013.05.102. Epub 2013 Jun 11.

PMID:
23845218
2.

Effect of insulin analogues on insulin/IGF1 hybrid receptors: increased activation by glargine but not by its metabolites M1 and M2.

Pierre-Eugene C, Pagesy P, Nguyen TT, Neuillé M, Tschank G, Tennagels N, Hampe C, Issad T.

PLoS One. 2012;7(7):e41992. doi: 10.1371/journal.pone.0041992. Epub 2012 Jul 26.

3.

In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites.

Sommerfeld MR, Müller G, Tschank G, Seipke G, Habermann P, Kurrle R, Tennagels N.

PLoS One. 2010 Mar 4;5(3):e9540. doi: 10.1371/journal.pone.0009540.

4.

Gene expression profiling in skeletal muscle of Zucker diabetic fatty rats: implications for a role of stearoyl-CoA desaturase 1 in insulin resistance.

Voss MD, Beha A, Tennagels N, Tschank G, Herling AW, Quint M, Gerl M, Metz-Weidmann C, Haun G, Korn M.

Diabetologia. 2005 Dec;48(12):2622-30. Epub 2005 Nov 12.

PMID:
16284748
5.
6.

Selective inhibition of hepatic collagen accumulation in experimental liver fibrosis in rats by a new prolyl 4-hydroxylase inhibitor.

Bickel M, Baringhaus KH, Gerl M, Günzler V, Kanta J, Schmidts L, Stapf M, Tschank G, Weidmann K, Werner U.

Hepatology. 1998 Aug;28(2):404-11.

PMID:
9696004
7.

Inhibition of prolyl 4-hydroxylase by oxalyl amino acid derivatives in vitro, in isolated microsomes and in embryonic chicken tissues.

Baader E, Tschank G, Baringhaus KH, Burghard H, Günzler V.

Biochem J. 1994 Jun 1;300 ( Pt 2):525-30.

8.

Structural requirements for the utilization of ascorbate analogues in the prolyl 4-hydroxylase reaction.

Tschank G, Sanders J, Baringhaus KH, Dallacker F, Kivirikko KI, Günzler V.

Biochem J. 1994 May 15;300 ( Pt 1):75-9.

9.
10.

Isolation and characterization of a 60-70-kD plasma membrane glycoprotein involved in the contact-dependent inhibition of growth.

Wieser RJ, Schütz S, Tschank G, Thomas H, Dienes HP, Oesch F.

J Cell Biol. 1990 Dec;111(6 Pt 1):2681-92.

11.

The effectiveness of inhibitors of soluble prolyl hydroxylase against the enzyme in the cisternae of isolated bone microsomes.

Tschank G, Hanauske-Abel HM, Peterkofsky B.

Arch Biochem Biophys. 1988 Mar;261(2):312-23.

PMID:
2833164
13.

Pyrroloquinoline quinone and molecules mimicking its functional domains. Modulators of connective tissue formation?

Hanauske-Abel HM, Tschank G, Günzler V, Baader E, Gallop P.

FEBS Lett. 1987 Apr 20;214(2):236-43. Review. No abstract available.

14.

Butyrate-synchronized cloned T cells retain their dependence on interleukin-2 for growth induction. A model system for growth regulation.

Moebius U, Günzler V, Hanauske-Abel HM, Spaeth E, Rüde E, Tschank G.

Exp Cell Res. 1987 Apr;169(2):379-84.

PMID:
3493914
15.

Iron-dependent uptake of ascorbate into isolated microsomes.

Peterkofsky B, Tschank G, Luedke C.

Arch Biochem Biophys. 1987 Apr;254(1):282-9.

PMID:
3034160
16.

Immunological effects of thalidomide. Inactivity of the drug and several of its hydrolysis products in mononucleocyte proliferation tests.

Günzler V, Hanauske-Abel HM, Tschank G, Schulte-Wissermann H.

Arzneimittelforschung. 1986 Jul;36(7):1138-41.

PMID:
2945568
17.

Effects of hydrazyl group containing drugs on leucocyte functions: an immunoregulatory model for the hydralazine-induced lupus-like syndrome.

Schopf RE, Hanauske-Abel HM, Tschank G, Schulte-Wissermann H, Günzler V.

J Immunopharmacol. 1985;7(4):385-401.

PMID:
2868061
18.

Contracting striated muscle fibres differentiated from primary rat pituitary cultures.

Brunner G, Tschank G.

Cell Tissue Res. 1982;224(3):655-62.

PMID:
7116417

Supplemental Content

Loading ...
Support Center